Hervycta plus 440 mg Injection
$716.60
$333.18
Hervycta Plus 440 mg Injection is an innovative treatment option for patients battling metastatic breast cancer and metastatic gastric cancer. This powerful monoclonal antibody specifically targets the HER2/neu receptor, effectively disrupting the growth and replication of certain cancerous tumor cells. By honing in on these aggressive cells, Hervycta Plus plays a crucial role in managing and slowing the progression of these challenging cancers. While it offers significant therapeutic benefits, patients should be aware of potential side effects, including common reactions at the injection site and systemic effects like fatigue. It’s essential to consult with a healthcare professional to discuss any existing health conditions or medications, as these may influence treatment outcomes. With its targeted approach, Hervycta Plus 440 mg Injection represents a promising advance in cancer care, enhancing the quality of life for those affected by these serious conditions. Always follow your physician's guidance for optimal results and safety during treatment.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Hervycta plus 440 mg injection is utilized in the treatment of stomach cancer, which originates in the stomach's lining. This medication helps to manage the progression of the disease, providing essential support for patients facing this challenging diagnosis. By targeting specific pathways involved in cancer growth, Hervycta plus 440 mg injection aids in controlling symptoms and improving the quality of life for those affected. It is typically administered in clinical settings under the guidance of healthcare professionals.
• In addition to stomach cancer, Hervycta plus 440 mg injection is effective in addressing breast cancer, a condition that arises in the breast tissue. This injection works by disrupting the cancer cells' ability to proliferate, thus slowing down the disease's advancement. Patients receiving Hervycta plus 440 mg injection may experience a reduction in tumor size and a better overall response to their treatment regimen. Oncologists often recommend this medication as part of a comprehensive treatment plan.
• Hervycta plus 440 mg injection can also be indicated for patients with specific types of cancers that may benefit from targeted therapy. By focusing on unique molecular characteristics of the tumors, this injection enhances treatment efficacy. Oncologists may choose Hervycta plus 440 mg injection to provide a tailored approach to cancer management, ensuring that patients receive the most appropriate care based on their individual needs. Its use in these scenarios reflects the evolving strategies in oncology to improve patient outcomes.
• The administration of Hervycta plus 440 mg injection is often part of a multidisciplinary approach to cancer treatment, combining various therapeutic modalities. Healthcare providers may incorporate this injection to enhance the overall effectiveness of chemotherapy or radiation therapy. By utilizing Hervycta plus 440 mg injection, clinicians aim to optimize patient response and minimize disease recurrence. This collaborative effort underscores the importance of personalized medicine in oncology care.
Benefits
Breast cancer: Hervycta plus 440 mg Injection is used for the treatment of breast cancer when there has been no significant improvement with other medicines. It helps stop the growth and spread of the cancer, and relieves symptoms of breast cancer, such as lumps in the breast, nipple discharge, or changes in the shape or texture of the breast. A doctor or nurse will give this medicine by injection. To get the most benefit, follow your doctor's instructions carefully.
Stomach cancer: Stomach cancer, also known as gastric cancer, can occur in the inner lining (called the lining) of the stomach or in the walls of the stomach. There are different types of stomach cancer depending on where it starts, the area affected and the severity of the cancer. Hervycta plus 440 mg helps kill cancer cells and stop them from growing and spreading. To get the most benefit, follow your doctor's instructions carefully.
Side Effects
Like all medicines, Hervycta plus 440 mg Injection may cause side effects that do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Infection
• Fever
• Weight Loss
• Appetite Loss
• Skin Rashes
• Constipation
• Reduce in Blood Count
• Heartburn
• Runny nose
• Hair Loss
• Muscle and Joint Pain
Common Side Effects
• Congestive heart failure
• Lung problems
• Trouble in breathing
• Fluid in the lungs
How To Use
Hervycta plus Injection is an intravenous infusion, administered under the supervision of your doctor or a nurse in a hospital. Self-administration is not recommended to the patient.
Safety Advice
• Alcohol: Drinking alcohol while taking Hervycta plus 440 Injection is generally not recommended. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol intake while taking any medication.
• Kidney: It is safe to use Hervycta plus Injection in patients with kidney disease. No dose adjustment of Hervycta plus 440 mg Injection is recommended. If you experience any side effects, please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Hervycta plus 440 Injection. Hervycta plus 440 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Hervycta plus 440 mg Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Hervycta plus Injection is safe for use in patients with mild to moderate liver disease, no dose adjustment of Hervycta plus 440 mg Injection is recommended. The use of Hervycta plus 440 mg Injection is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Hervycta plus 440 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Hervycta plus Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Hervycta plus 440 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Hervycta plus 440 Injection.